Lawrence Eichenfield, MD, discusses how the treatment landscape for atopic dermatitis has changed in recent years and provides clinical insights on the clinical burden and most burdensome symptoms of the disease.
Can Lecanemab Succeed Where Aduhelm Failed?
September 28th 2022The announcement of positive phase 3 results for the investigational Alzheimer’s disease drug comes against a backdrop of Aduhelm flaming out. Both drugs are predicated on the theory that Alzheimer’s is caused by beta-amyloid deposits.
Read More